Month: September 2021

WHO: Most of Africa Has Missed 10 Percent COVID-19 Vaccination Goal

GENEVA — Fifteen African countries have succeeded in fully vaccinating at least 10 percent of their populations against COVID-19 by September 30, a goal set by the World Health Organization in May. However, that leaves two-thirds of the continent’s 54 …

South Africa’s Coal Energy Sector Under Mounting Pressure

JOHANNESBURG — Coal provides more than 75% of South Africa’s energy supply, but in the wake of global warming, pressure is mounting for that to change. Protests were seen across the country last week and now a proposed Chinese-backed coal power plant m…

UN Chief ‘Shocked’ as Ethiopia Expels 7 Aid Officials

NEW YORK — The U.N. secretary-general expressed “shock” Thursday after the Ethiopian government announced the expulsion of seven senior U.N. humanitarian officials working in the country.“In Ethiopia, the U.N. is delivering lifesaving aid — including f…

Nigerian Police Deny Killing Members of Banned Shiite Group

ABUJA, NIGERIA — Nigerian police have denied killing any members of a banned Shiite Muslim group during a gathering this week in the capital, Abuja.The Islamic Movement of Nigeria said police on Tuesday shot and killed eight of its members as they mark…

Delayed Elections Are Underway in Ethiopia

Delayed elections are underway Thursday in four regions of Ethiopia.Voters in three regions will decide who wins dozens of parliamentary seats in the last round of voting before Prime Minister Abiy Ahmed forms a new government on Oct. 4.Voters in the f…

Sinocare présente ses produits pour la gestion du diabète et des maladies chroniques lors de la deuxième exposition économique et commerciale Chine-Afrique

CHANGSHA, Chine, 29 septembre 2021 /PRNewswire/ — Sinocare, le leader mondial du développement de tests médicaux, a présenté sa dernière gamme de produits lors de la deuxième exposition économique et commerciale Chine-Afrique (CAETE), qui s’est tenue du 26 au 29 septembre au centre international de congrès et d’expositions de Changsha. Sinocare

Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19

ADG20 Continues to be Well Tolerated in Healthy Volunteers with Prolonged Half-Life and Serum Virus Neutralization Activity Observed out to Six Months in Ongoing Phase 1 Study Data from Quantitative Systems Pharmacology/Whole-Body Physiologically Based Pharmacokinetic Modeling Support Evaluation of 300 mg Intramuscular Dose of ADG20 Given as a Single Intramuscular